CJC-1295 No DAC + Ipamorelin

Overview

CJC-1295 without DAC, also called modified GRF (1-29), is a short-acting analogue of growth-hormone-releasing hormone (GHRH). Ipamorelin is a small peptide that activates the ghrelin receptor (GHS-R1a), a separate pathway that also triggers growth-hormone release.

Combining a GHRH analogue with a ghrelin-receptor agonist is studied because the two act together on the pituitary. Ipamorelin is known for its selectivity, with little effect on cortisol or prolactin in published studies.

Research areas

• Pulsatile growth-hormone release from the pituitary
• Synergy between GHRH and ghrelin-receptor signalling
• IGF-1 levels, body composition and recovery models

Specifications

Category

Growth & hormones

Compound

Blend: GHRH analogue + growth-hormone secretagogue

Structure

CJC-1295 without DAC (modified GRF 1-29, 29 amino acids) + ipamorelin (5 amino acids)

Form

Lyophilised (freeze-dried) powder in sealed vials

Available as

5mg+10mg (10 vials)

Quality

Third-party tested

Storage and handling

Unopened vials: freezer (−20 °C) for long-term storage, or refrigerator (2–8 °C) for shorter periods. Keep away from light and moisture. After reconstitution, keep refrigerated.